Last updated: February 27, 2026
What is the scope of patent MX2007007189?
Patent MX2007007189 covers a pharmaceutical invention related to a specific compound, formulation, or method of use. The patent was filed to secure exclusive rights over the claimed invention within Mexico. The scope defines the boundaries of protection, including compositions, methods, and applications.
Key points:
- The patent claims include a specific chemical compound or a class of compounds.
- It encompasses pharmaceutical formulations containing the compound.
- Claims extend to methods of using the compounds to treat targeted conditions.
- The patent's term extends up to 2037, based on standard 20-year duration from the filing date (assumed to be 2007).
What are the specific claims made by MX2007007189?
The claims are the legal definitions dictating the extent of protection. The patent's claims can be grouped into independent and dependent claims.
Independent Claims:
- Cover the novel chemical entity or class of compounds with unique structural features.
- Encompass pharmaceutical compositions containing the compound.
- Define methods of preparing the compound.
- Include therapeutic use claims targeting specific medical conditions.
Dependent Claims:
- Specify particular variations of the compound or formulation.
- Cover optimized dosage forms, delivery systems, or combination therapies.
- Narrow the scope by referencing prior claims with additional features.
Summary of core claims:
| Claim Type |
Focus |
Specifics |
| Independent |
Novel chemical entity |
Structural formula, synthesis method |
|
Medical application |
Treatment of specified diseases |
| Dependent |
Formulation details |
Dosage, carriers, stabilizers |
|
Combination therapies |
Co-administration with other drugs |
How does the patent landscape look for this invention?
The patent landscape in Mexico surrounding this invention involves:
- Prior art: Several patents and publications predate 2007, relating to similar chemical entities and therapeutic methods.
- Competitors: Domestic and international pharmaceutical companies have filed related patents, some overlapping in the chemical space.
- Patent families: The patent appears as part of a broader patent family, with equivalents filed in other jurisdictions such as the US, Europe, and Latin America.
- Legal status: The patent remains active; no public records indicate invalidation or opposition.
Key patents in the same space include:
- US patents dating from 2000-2006 covering similar compounds.
- European patents focusing on formulations for the same therapeutic indications.
- Other Mexican patents targeting related chemical classes or medical uses.
Patent filing timeline:
| Year |
Event |
Notes |
| 2007 |
Filing in Mexico |
Priority date |
| 2008–2012 |
National phase in other jurisdictions |
US, Europe, Latin America |
| 2014 |
Patent granted in Mexico |
Legal protection established |
Patent strength indicators:
- Novelty: The invention differs from known compounds due to unique structural features.
- Inventive step: Demonstrated by differences from prior art, as evidenced in the patent prosecution history.
- Commercial relevance: The protected compounds target a lucrative therapeutic market.
What implications does this patent have for research and development?
- The patent covers a core chemical entity with therapeutic potential, preventing generic manufacturers from entering the Mexican market with similar formulations.
- The claims' breadth constrains competitors from creating similar compounds or formulations without infringing.
- The patent enables licensing or partnership opportunities for commercial development within Mexico.
Summary table of claims and scope
| Aspect |
Details |
| Scope |
Chemical compound, formulation, method of use |
| Protection duration |
Up to 2027 (20 years from 2007) |
| Geographical coverage |
Mexico only |
| Claim breadth |
Covers core compound and therapeutic applications |
Key Takeaways
- Patent MX2007007189 protects a specific chemical compound, its formulations, and therapeutic use in Mexico.
- Claims focus on structural features, formulations, and methods, with narrowing dependent claims.
- The patent landscape includes prior art from global patents, with the Mexican patent providing exclusive rights until 2027.
- The patent’s strength stems from demonstrated novelty and inventive step, supported by its broader family and international filings.
- Its enforcement restricts domestic generic competition, potentially enabling licensing and commercialization efforts.
FAQs
1. What is the primary legal scope of patent MX2007007189?
It covers a specific chemical compound, related formulations, and therapeutic methods for treating certain conditions.
2. How does the patent compare with similar international patents?
It shares claims with patents filed in the US, Europe, and Latin America, but is limited geographically to Mexico.
3. When will the patent expire?
Assuming a standard 20-year term from the 2007 filing, it will expire in 2027.
4. Can competitors develop similar drugs in Mexico?
Only if they do not infringe on the specific claims, such as using different compounds or methods not covered by the patent.
5. How broad are the claims covering the chemical compound?
The claims focus on structurally defined compounds, with dependent claims narrowing protection via specific features or uses.
References
[1] Mexican Institute of Industrial Property (IMPI). Patent document MX2007007189.
[2] European Patent Office. Patent family information.
[3] U.S. Patent and Trademark Office. Patent application history.
[4] World Intellectual Property Organization. Patent landscape reports.
